e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Pulmonary circulation: clinical pulmonary hypertension II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Out of proportion PH in COPD: Report of a small case series
D. Piloni, T. Oggionni, L. Diachyshyna, L. Scelsi, S. Ghio, C. Raineri, I. Cerveri, A. Cascina, F. Meloni (Pavia, Italy)
Source:
Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Session:
Pulmonary circulation: clinical pulmonary hypertension II
Session type:
Thematic Poster Session
Number:
2647
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Piloni, T. Oggionni, L. Diachyshyna, L. Scelsi, S. Ghio, C. Raineri, I. Cerveri, A. Cascina, F. Meloni (Pavia, Italy). Out of proportion PH in COPD: Report of a small case series. Eur Respir J 2013; 42: Suppl. 57, 2647
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Imaging of complicated pneumonia: what is new?
Emerging classes of drugs for the treatment of obstructive lung disease
Related content which might interest you:
Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey
Source: International Congress 2014 – Clinical presentations
Year: 2014
Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014
The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
GOLD and phenotypes: The new Czech COPD guidelines
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Management of virtual COPD cases by pulmonary physicians
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Are there any differences between Tunisian and European COPD phenotypes?
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Eosinophilic airway inflammation as a complication of COPD, and the usefulness of ICS on these cases
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Misdiagnosed COPD: systematic review and meta-analysis
Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care
Year: 2007
Clinical Impact of Gensini score in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease
Source: International Congress 2016 – Smoking-related diseases
Year: 2016
COPD and clinical phenotypes: Patients with concomitant pulmonary hypertension may be less likely to be frequent exacerbators
Source: International Congress 2014 – Clinical presentations
Year: 2014
microRNA profile in COPD patients with and without pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Outcomes of COPD exacerbations - a report from the ERS COPD audit in Austria
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Heterogeneity of group D in the new GOLD classification of COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Clustering asthma and COPD provides new evidence for both “British” and “Dutch” hypotheses of COPD development
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Clinical case on COPD: an unexpectedly long story with an unforeseen end
Source: Annual Congress 2007 - Clinical Grand Round: an interactive session
Year: 2007
Heterogeneity inside group D COPD patients: About 827 cases
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept